Steven Cohen’s Viridian Therapeutics VRDN Stock Holding History
Bought
Maintained
Sold
Other funds holding VRDN
KCM
Steven Cohen's VRDN Position: Q3 2026 in Review
Steven Cohen increased its Viridian Therapeutics (VRDN) stake by 98% in Q3 2026, buying an estimated $48.9M and bringing the position to 4,633,544 shares worth $95.4M. The position accounts for 0.11% of the portfolio, ranked #219.
Steven Cohen first reported a position in VRDN in Q3 2018 and has held it in 24 quarters since. 235 funds tracked by Wall St. Rank hold VRDN as of Q3 2026.
- Steven Cohen held 4,633,544 shares of Viridian Therapeutics worth $95.4M as of Q3 2026.
- Steven Cohen bought 2,290,336 Viridian Therapeutics shares in Q3 2026, an estimated $48.9M.
- Viridian Therapeutics made up 0.11% of Steven Cohen's portfolio in Q3 2026, its #219 holding.
- Steven Cohen first reported a position in Viridian Therapeutics in Q3 2018 and has held it in 24 quarters since.
- 235 funds tracked by Wall St. Rank held Viridian Therapeutics as of Q3 2026.
Based on Point72 Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.